NCT06955702View on ClinicalTrials.gov

Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2026

Conditions
Breast NeoplasmsAlopeciaMadarosisEyebrow DiseasesEyelash DiseasesAnthracyclinesTaxoidsSide Effects
Interventions
DEVICE

cryotherapy for chemotherapy-induced madarosis

Application of temperature-controlled cold devices (-4°C to -7°C) to the supraorbital area (up to 3 cm above the eyelid margin), administered 15 minutes before chemotherapy infusion and maintained for 20 minutes post-infusion.

Trial Locations (2)

37007

RECRUITING

Hospital Universitario de Salamanca, Salamanca

39011

RECRUITING

Hospital Marqués de Valdecilla, Santander

All Listed Sponsors
lead

University of Salamanca

OTHER